CA1005062A - Process for producing tetrahydrocarbazole derivatives - Google Patents

Process for producing tetrahydrocarbazole derivatives

Info

Publication number
CA1005062A
CA1005062A CA172,234A CA172234A CA1005062A CA 1005062 A CA1005062 A CA 1005062A CA 172234 A CA172234 A CA 172234A CA 1005062 A CA1005062 A CA 1005062A
Authority
CA
Canada
Prior art keywords
producing
tetrahydrocarbazole derivatives
tetrahydrocarbazole
derivatives
producing tetrahydrocarbazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA172,234A
Other languages
English (en)
Other versions
CA172234S (en
Inventor
Helmut Biere
Clemens Rufer
Ekkehard Schillinger
Olaf Loge
Eberhard Schroder
Hanns Ahrens
Wolfgang Losert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of CA1005062A publication Critical patent/CA1005062A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
CA172,234A 1972-05-25 1973-05-25 Process for producing tetrahydrocarbazole derivatives Expired CA1005062A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722226703 DE2226703A1 (de) 1972-05-25 1972-05-25 Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
CA1005062A true CA1005062A (en) 1977-02-08

Family

ID=5846530

Family Applications (1)

Application Number Title Priority Date Filing Date
CA172,234A Expired CA1005062A (en) 1972-05-25 1973-05-25 Process for producing tetrahydrocarbazole derivatives

Country Status (12)

Country Link
JP (1) JPS4941367A (enExample)
AT (1) AT323155B (enExample)
AU (1) AU5607873A (enExample)
BE (1) BE800066A (enExample)
CA (1) CA1005062A (enExample)
CH (1) CH582144A5 (enExample)
CS (1) CS179416B2 (enExample)
DD (1) DD106170A5 (enExample)
DE (1) DE2226703A1 (enExample)
FR (1) FR2185414B1 (enExample)
GB (1) GB1436893A (enExample)
NL (1) NL7307313A (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235903A (en) * 1979-08-06 1980-11-25 American Home Products Corporation 1-Hydroxyalkanamine tetrahydrocarbazoles and cyclopent[b]indoles, compositions and method of use
US7151100B1 (en) 1999-07-23 2006-12-19 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7129262B2 (en) 1999-07-23 2006-10-31 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US6545034B1 (en) 1999-07-23 2003-04-08 The Regents Of The University Of California Use of etodolac for the treatment of chronic lymphocytic leukemia
US7361680B2 (en) 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
DE10164564B4 (de) * 2001-12-14 2007-05-16 Zentaris Gmbh Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR)
WO2004026116A2 (en) 2002-09-19 2004-04-01 The Regents Of The University Of California Use of etodoclac to treat hyperplasia
CA2538759C (en) * 2003-09-12 2015-11-03 Elixir Pharmaceuticals, Inc. Substituted heterocyclic compounds as sirtuin inhitibitors
US20060074124A1 (en) * 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
CA2540343A1 (en) * 2003-10-02 2005-04-14 Cephalon, Inc. Indole derivatives
US8580841B2 (en) * 2008-07-23 2013-11-12 Arena Pharmaceuticals, Inc. Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
CN105816453B (zh) 2008-08-27 2021-03-05 艾尼纳制药公司 用于治疗自身免疫性病症和炎性病症的作为s1p1受体激动剂的经取代的三环酸衍生物
SG182610A1 (en) 2010-01-27 2012-08-30 Arena Pharm Inc Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
CA2789480A1 (en) 2010-03-03 2011-09-09 Arena Pharmaceuticals, Inc. Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
US11007175B2 (en) 2015-01-06 2021-05-18 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
BR112017027656B1 (pt) 2015-06-22 2023-12-05 Arena Pharmaceuticals, Inc. Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo
CA3053418A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
JP2020507610A (ja) 2017-02-16 2020-03-12 アリーナ ファーマシューティカルズ， インコーポレイテッド 腸管外症状を伴う炎症性腸疾患の治療のための化合物および方法
BR112020024762A2 (pt) 2018-06-06 2021-03-23 Arena Pharmaceuticals, Inc. métodos de tratamento de condições relacionadas ao receptor s1p1
CN119751336A (zh) 2018-09-06 2025-04-04 艾尼纳制药公司 可用于治疗自身免疫性病症和炎性病症的化合物
CN114634442B (zh) * 2022-04-02 2023-10-13 内蒙古民族大学 一种四氢咔唑酮化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH586678A5 (enExample) * 1970-05-25 1977-04-15 Hoffmann La Roche
ZA715217B (en) * 1970-08-20 1972-04-26 Org Nv Anti-inflammatory preparations

Also Published As

Publication number Publication date
DD106170A5 (enExample) 1974-06-05
AU5607873A (en) 1974-11-28
FR2185414B1 (enExample) 1976-08-13
GB1436893A (en) 1976-05-26
NL7307313A (enExample) 1973-11-27
CH582144A5 (enExample) 1976-11-30
CS179416B2 (en) 1977-10-31
FR2185414A1 (enExample) 1974-01-04
BE800066A (fr) 1973-11-26
JPS4941367A (enExample) 1974-04-18
AT323155B (de) 1975-06-25
DE2226703A1 (de) 1973-12-13

Similar Documents

Publication Publication Date Title
CA1005062A (en) Process for producing tetrahydrocarbazole derivatives
HU172703B (hu) Sposob poluchenija proizvodnykh 16-fenoksi-omega-tetranor-prostaglandina
CA1021097A (en) Process for preparing poly-ion-complexes
HU172069B (hu) Sposob poluchenija proizvodnykh 1-skobka-3-dvojjnozamehhennykh-fosfono-tioureido-skobka zakryta-2-skobka-3-zamehhennykh-ureido- ili -tioureido-skobka zakryta-benzolov
CA1030151A (en) Process for producing 9,10-seco-oestrane derivatives
CA1034115A (en) Process for producing desacetoxycephalosporin derivatives
CA983956A (en) Process for preparing monoformyldiaminomaleonitrile
HU173381B (hu) Sposob poluchenija proizvodnykh karboksi-ciklopropanov
CA967976A (en) Process for producing trimethyl-p-benzoquinone
CA987326A (en) Process for producing 2-acyl-5-nitrothiazoles
AU467691B2 (en) Process for preparing cedrenal
AU476254B2 (en) Process for producing chromone derivatives
CA900476A (en) Process for producing 1-aminoalkylbenzodiazepine derivatives
CA894235A (en) Process for producing 1-acylindole derivatives
CA894214A (en) Process for producing l-tryptophan
CA903691A (en) Process for producing l-tryptophan
CA903692A (en) Process for producing l-tryptophan
AU459799B2 (en) Process for producing indan derivatives
CA893098A (en) Process for producing l-threonine
CA980047A (en) Process for preparing polythiodiglycol
CA893702A (en) Process for producing benzodiazepine derivatives
CA893122A (en) Process for producing benzodiazepine derivatives
CA903207A (en) Process for producing benzodiazepine derivatives
CA909219A (en) Process for producing benzodiazepine derivatives
CA905938A (en) Process for producing 5-bromo-6-fluoro-steroids